CH540695A - Manufacturing process of medicinal chemical compounds - Google Patents

Manufacturing process of medicinal chemical compounds

Info

Publication number
CH540695A
CH540695A CH598872A CH598872A CH540695A CH 540695 A CH540695 A CH 540695A CH 598872 A CH598872 A CH 598872A CH 598872 A CH598872 A CH 598872A CH 540695 A CH540695 A CH 540695A
Authority
CH
Switzerland
Prior art keywords
manufacturing process
chemical compounds
medicinal chemical
medicinal
compounds
Prior art date
Application number
CH598872A
Other languages
French (fr)
Original Assignee
Sasuco S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sasuco S A filed Critical Sasuco S A
Publication of CH540695A publication Critical patent/CH540695A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
CH598872A 1971-04-26 1972-04-21 Manufacturing process of medicinal chemical compounds CH540695A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LU63060 1971-04-26

Publications (1)

Publication Number Publication Date
CH540695A true CH540695A (en) 1973-08-31

Family

ID=19726690

Family Applications (1)

Application Number Title Priority Date Filing Date
CH598872A CH540695A (en) 1971-04-26 1972-04-21 Manufacturing process of medicinal chemical compounds

Country Status (6)

Country Link
CH (1) CH540695A (en)
DE (1) DE2220504A1 (en)
FR (1) FR2134503B1 (en)
GB (1) GB1358001A (en)
LU (1) LU63060A1 (en)
NL (1) NL7205573A (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9103110D0 (en) 1991-10-24 1991-10-24 Kabi Pharmacia Ab NEW DRUG FORMULATION
CA2355829A1 (en) * 1999-01-07 2000-07-13 Louise Templeton Multiparticulate oral dosage forms
EP2018160B1 (en) 2006-03-16 2011-12-14 Tris Pharma, Inc. Modified release formulations containing drug-ion exchange resin complexes
BR112015003120B1 (en) 2012-08-15 2022-08-09 Tris Pharma , Inc METHYLPHENIDATE EXTENDED RELEASE CHEW TABLET AND ITS USE
US11590228B1 (en) 2015-09-08 2023-02-28 Tris Pharma, Inc Extended release amphetamine compositions
US11590081B1 (en) 2017-09-24 2023-02-28 Tris Pharma, Inc Extended release amphetamine tablets

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR7017E (en) *
BE560809A (en) *

Also Published As

Publication number Publication date
LU63060A1 (en) 1971-08-26
GB1358001A (en) 1974-06-26
FR2134503B1 (en) 1976-07-02
DE2220504A1 (en) 1973-02-15
NL7205573A (en) 1972-10-30
FR2134503A1 (en) 1972-12-08

Similar Documents

Publication Publication Date Title
CH406154A (en) Manufacturing process of tiny capsules
CH453361A (en) Process for the preparation of therapeutically active chemical compounds
CH540196A (en) Sodium percabonate manufacturing process
FR1434080A (en) Manufacturing process of nitrogen compounds
CH464932A (en) Process for the preparation of new chemical compounds
CH494063A (en) Manufacturing process of tiny polymer capsules
CH542882A (en) Process for the preparation of α-thio-ureidocephalosporanic acid compounds
CH532034A (en) Process for the preparation of substituted dibenzo-oxepine-spiro-dioxolanes
OA03909A (en) Process for the preparation of chemical compounds.
CH543517A (en) Process for the preparation of new chemical antiparasitic compounds
CH540695A (en) Manufacturing process of medicinal chemical compounds
CH524646A (en) Manufacturing process of heterocyclic polymers
CH539023A (en) Process for the preparation of new polyfluoroamino compounds
BR7202718D0 (en) OXIDATION PROCESS OF DEFINED COMPOUNDS
CH494716A (en) Process for the production of cyclic compounds
CH402863A (en) Process for the preparation of new therapeutically active chemical compounds
OA05105A (en) Process for the manufacture of anti-atheromatous compounds.
CH540206A (en) Perfluorination process for functional perchlorinated compounds
CH542168A (en) Process for the preparation of new surfactant compounds
CH493444A (en) Process for the preparation of cyclic organic chemical compounds
CH511781A (en) Manufacturing process of para-tertio-butyl-phenol
CH545299A (en) Methylcobalamin manufacturing process
CH527143A (en) Process for the preparation of new surfactant compounds
BE786638A (en) PROCESS FOR TREATING BY-PRODUCTS OF LABAR MANUFACTURING
CH545270A (en) Process for the preparation of substituted phenyl compounds

Legal Events

Date Code Title Description
PL Patent ceased